George Adi Mor
CIK: 0001851069
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Chemomab Therapeutics Ltd.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 29, 2026CMMB
Chemomab Therapeutics Ltd.
Purchase(P)Direct4.9K shares at avg. $2.05$10K - May 29, 2026CMMB
Chemomab Therapeutics Ltd.
Purchase(P)Direct4.9K shares at avg. $2.08$10K - May 29, 2026CMMB
Chemomab Therapeutics Ltd.
Other(J)Direct31.7K shares- - May 29, 2026CMMB
Chemomab Therapeutics Ltd.
Other(J)Direct18.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | CMMB Chemomab Therapeutics Ltd. | Purchase(P) | 4,878 | $2.05 | $10,000 | Direct |
| May 29, 2026 | CMMB Chemomab Therapeutics Ltd. | Purchase(P) | 4,926 | $2.08 | $10,246 | Direct |
| May 29, 2026 | CMMB Chemomab Therapeutics Ltd. | Other(J) | 31,712 | - | $0 | Direct |
| May 29, 2026 | CMMB Chemomab Therapeutics Ltd. | Other(J) | 18,750 | - | $0 | Direct |
1-4 of 4 transactions
About Mor George Adi
Mor George Adi (SEC CIK 0001851069) files insider reports with the SEC as Chief Executive Officer of Chemomab Therapeutics Ltd. (CMMB).
Signal8 holds 2 ownership filings by Mor George Adi (1 Form 3, 1 Form 4), filed between Apr 10, 2026 and Jun 1, 2026. Those filings report 4 transactions, the latest on May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mor George Adi's filings is in TEL AVIV.
Recent filings by Mor George Adi
Other insiders filing for Chemomab Therapeutics Ltd. (CMMB)
- Cohen Neil Harris, Director
- Melincoff Gwen A, Director
- Darvish Nissim, Director
- Moses Alan Charles, Director
- Fatal Sigal, Chief Financial Officer
- Lawler John, Chief Development Officer